Cargando…
Epidemiology of Hepatitis C Virus (HCV) Infection
Hepatitis C virus remains a large health care burden to the world. Incidence rates across the world fluctuate and are difficult to calculate given the asymptomatic, often latent nature of the disease prior to clinical presentation. Prevalence rates across the world have changed as well with more cou...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1415844/ https://www.ncbi.nlm.nih.gov/pubmed/16614741 |
_version_ | 1782127130451116032 |
---|---|
author | Sy, Theodore Jamal, M. Mazen |
author_facet | Sy, Theodore Jamal, M. Mazen |
author_sort | Sy, Theodore |
collection | PubMed |
description | Hepatitis C virus remains a large health care burden to the world. Incidence rates across the world fluctuate and are difficult to calculate given the asymptomatic, often latent nature of the disease prior to clinical presentation. Prevalence rates across the world have changed as well with more countries aware of transfusion-related hepatitis C and more and more evidence supporting intravenous drug use as the leading risk factor of spread of the virus. This article reviews current hepatitis C virus prevalence and genotype data and examines the different risk factors associated with the virus. |
format | Text |
id | pubmed-1415844 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-14158442006-04-13 Epidemiology of Hepatitis C Virus (HCV) Infection Sy, Theodore Jamal, M. Mazen Int J Med Sci Review Hepatitis C virus remains a large health care burden to the world. Incidence rates across the world fluctuate and are difficult to calculate given the asymptomatic, often latent nature of the disease prior to clinical presentation. Prevalence rates across the world have changed as well with more countries aware of transfusion-related hepatitis C and more and more evidence supporting intravenous drug use as the leading risk factor of spread of the virus. This article reviews current hepatitis C virus prevalence and genotype data and examines the different risk factors associated with the virus. Ivyspring International Publisher 2006-04-01 /pmc/articles/PMC1415844/ /pubmed/16614741 Text en © Ivyspring International Publisher. This is an open access article. Reproduction is permitted for personal and noncommerical use, provided that the article is in whole, unmodified, and properly cited. |
spellingShingle | Review Sy, Theodore Jamal, M. Mazen Epidemiology of Hepatitis C Virus (HCV) Infection |
title | Epidemiology of Hepatitis C Virus (HCV) Infection |
title_full | Epidemiology of Hepatitis C Virus (HCV) Infection |
title_fullStr | Epidemiology of Hepatitis C Virus (HCV) Infection |
title_full_unstemmed | Epidemiology of Hepatitis C Virus (HCV) Infection |
title_short | Epidemiology of Hepatitis C Virus (HCV) Infection |
title_sort | epidemiology of hepatitis c virus (hcv) infection |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1415844/ https://www.ncbi.nlm.nih.gov/pubmed/16614741 |
work_keys_str_mv | AT sytheodore epidemiologyofhepatitiscvirushcvinfection AT jamalmmazen epidemiologyofhepatitiscvirushcvinfection |